Skip to main content
SpringerLink
Log in

Quels carcinomes canalaires in situ ne pas traiter?

Which ductal carcinoma in situ of the breast could not be treated?

  • Conference paper
Cancer du sein : surdiagnostic, surtraitement

  • 230 Accesses

Résumé

Le carcinome canalaire in situ (CCIS) est une lésion précancéreuse développée au sein d’un canal galactophore dont la définition anatomopathologique est l’absence de franchissement de la membrane basale. La mortalité est faible de 1,5 à 2 % à 10 ans, il s’agit donc de lésions de très bon pronostic. L’auteur a déclaré n’avoir aucun lien d’intérêt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Références

  1. Ringberg A, Nordgren H, Thorstensson S et al. (2007) Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast—results from the Swedish randomised trial. Eur J Cancer 43: 291–298

    Article  PubMed  CAS  Google Scholar 

  2. Bijker N, Meijnen P, Peterse JL et al. (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24: 3381–3387

    Article  PubMed  Google Scholar 

  3. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100: 238–244

    Article  PubMed  Google Scholar 

  4. Cutuli B, Fourquet A, Luporsi E et al. (2005) Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bull Cancer 92: 155–168

    PubMed  Google Scholar 

  5. Silverstein MJ, Lagios MD, Groshen S et al. (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340: 1455–1461

    Article  PubMed  CAS  Google Scholar 

  6. MacGrogan G, Arnould L, de Mascarel I et al.; GEFPICS group (2008) Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions. Histopathology 52: 689–697

    Article  PubMed  CAS  Google Scholar 

  7. Jones JL (2006) Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast Cancer Res 8: 204

    Article  PubMed  Google Scholar 

  8. Tunon de Lara C, André G, McGrogan G et al. (2011) Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic and prognostic features. Retrospective study of 812 patients. Ann Surg Oncol 18: 1372–1379

    Article  PubMed  Google Scholar 

  9. Schmidt C (2011) Can some DCIS patients avoid adjuvant therapy? Still unknown. J Natl Cancer Inst 103: 530–531

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Bergonié, 229, cours de l’Argonne, 33076, Bordeaux Cedex

    C. Tunon de Lara

Authors
  1. C. Tunon de Lara
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Tunon de Lara, C. (2012). Quels carcinomes canalaires in situ ne pas traiter?. In: Cancer du sein : surdiagnostic, surtraitement. Springer, Paris. https://doi.org/10.1007/978-2-8178-0249-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0249-7_13

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0248-0

  • Online ISBN: 978-2-8178-0249-7

Publish with us

Policies and ethics

Search

Navigation